Infectious Disease & Vaccines
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 MRK | Merck & Co., Inc. | $271.8b | $111.89 | +0.5% | 1.8M |
 GILD | Gilead Sciences Inc | $160.4b | $130.11 | +0.4% | 1.8M |
 PFE | Pfizer Inc. | $150.6b | $25.32 | -0.0% | 12.4M |
 MRNA | Moderna, Inc. Common Stock | $18.7b | $48.21 | -1.7% | 2.1M |
 SMMT | Summit Therapeutics Inc. Common Stock | $16.5b | $16.13 | -4.4% | 1.1M |
 PCVX | Vaxcyte, Inc. Common Stock | $8.5b | $49.10 | -6.3% | 386.4K |
 BCRX | BioCryst Pharmaceuticals Inc | $2.3b | $8.90 | -1.3% | 973.3K |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.7b | $8.62 | -2.0% | 367.8K |
 NVAX | Novavax Inc | $1.3b | $9.13 | +0.7% | 1.7M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.8b | $4.14 | -2.2% | 304.4K |
 CRMD | CorMedix Inc. | $0.6b | $7.91 | +4.8% | 887.9K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $446.6m | $4.20 | +2.3% | 188.6K |
 ASMB | Assembly Biosciences, Inc | $429.1m | $26.95 | -5.9% | 61.3K |
 EBS | Emergent Biosolutions, Inc. | $425.0m | $8.20 | +3.2% | 430.0K |
 ENTA | Enanta Pharmaceuticals, Inc | $397.9m | $13.45 | +0.3% | 87.6K |
 IVVD | Invivyd, Inc. Common Stock | $390.3m | $1.15 | -5.4% | 1.9M |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $358.1m | $7.25 | -10.0% | 41.7K |
 SIGA | SIGA Technologies Inc. | $328.8m | $4.20 | +0.6% | 303.0K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $252.1m | $7.11 | -4.9% | 288.8K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $180.6m | $14.20 | -9.8% | 303.1K |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $170.6m | $4.40 | -7.3% | 36.9K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $154.6m | $2.67 | -4.5% | 680.0K |
 INO | Inovio Pharmaceuticals, Inc. | $93.8m | $1.33 | +2.7% | 2.6M |
 SCYX | SCYNEXIS, Inc. | $78.3m | $0.69 | -6.9% | 290.9K |
 XBIT | XBiotech Inc | $77.4m | $2.42 | -1.8% | 19.1K |
 IBO | Impact BioMedical, Inc. | $71.2m | $0.54 | +0.1% | 8.1K |
 MCRB | Seres Therapeutics, Inc. | $68.3m | $7.58 | -0.9% | 17.4K |
 ZTEK | Zentek Ltd. Common Stock | $48.3m | $0.69 | +0.7% | 37.0K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $47.3m | $4.80 | -0.9% | 17.7K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $38.9m | $5.55 | -2.8% | 83.8K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $30.9m | $14.52 | -1.9% | 7.8K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $27.0m | $8.05 | +1.3% | 7.9K |
 NNVC | NanoViricides Inc. | $26.1m | $1.49 | +0.7% | 651.8K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $19.2m | $1.22 | +1.3% | 115.7K |
 MBRX | Moleculin Biotech, Inc. | $13.7m | $2.04 | -3.1% | 125.6K |
 TRAW | Traws Pharma, Inc. Common Stock | $12.3m | $1.82 | -2.9% | 570.1K |
 IMNN | Imunon, Inc. Common Stock | $10.8m | $2.40 | -3.8% | 18.7K |
 PHGE | BiomX Inc. | $7.5m | $0.48 | -9.7% | 195.1K |
 XBIO | Xenetic Biosciences, Inc. | $7.2m | $3.01 | -1.1% | 1.8K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $7.1m | $0.82 | +0.2% | 32.5K |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $5.9m | $1.76 | -8.1% | 75.7K |
 CODX | Co-Diagnostics, Inc. Common Stock | $5.9m | $1.45 | +12.8% | 768.8K |
 SBFM | Sunshine Biopharma Inc. | $4.8m | $1.29 | +355.9% | 290.4M |
 SNGX | Soligenix, Inc. Common Stock | $4.3m | $0.37 | +3.4% | 3.6M |
 AIM | AIM ImmunoTech Inc. | $4.2m | $0.54 | +114.2% | 381.0M |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $4.2m | $1.46 | +4.7% | 20.4K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 AEMD | AETHLON MEDICAL INC | $3.4m | $2.13 | +1.4% | 635.9K |
 GOVX | GeoVax Labs, Inc. New | $3.2m | $2.54 | +106.9% | 169.6M |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $1.0m | $0.37 | +140.7% | 667.8M |